Why Corcept Therapeutics stock crashed today and what comes next?
Corcept Therapeutics (NASDAQ: CORT) crashed about 50% on Dec. 31 after the FDA requested additional data to support the efficacy of relacorilant,
Corcept Therapeutics (NASDAQ: CORT) crashed about 50% on Dec. 31 after the FDA requested additional data to support the efficacy of relacorilant,
Logan Mohtashami, a senior HousingWire analyst, believes mortgage rate stability – not rate cuts – will be the key driver for the
On December 1st, famed investor Jim Cramer looked into the camera on CNBC’s Mad Money and made a provocative statement – “maybe
Analysts increasingly believe Microsoft could reach a $5 trillion market valuation in early 2026.The analysis is driven by accelerating artificial intelligence monetisation,
Reflections and stock-taking are usually a part of the end-of-year celebrations. For investors in the crude oil market, 2025 has been a
Comex copper price is on track for a weekly loss even as the bulls remain in control during the holiday-shortened week. At
The S&P 500 Index and its ETFs, like SPY, VOO, and the IVV had a strong performance in 2025 as the technology
Officials with the Attorney General’s Office said Wednesday they are working relentlessly over the holidays to review and redact troves of documents
President Donald Trump claimed that California and Minnesota are both rife with fraud, slamming the two states and their respective governors as
Momentum on a 20-point peace plan to end the war between Russia and Ukraine is faltering after President Vladimir Putin accused Kyiv